June 17, 2020 / 11:36 AM / 22 days ago

BRIEF-Aclaris Supports Investigator-Initiated Clinical Trial Of ATI-450 For Cytokine Release Syndrome In Patients With COVID-19

June 17 (Reuters) - Aclaris Therapeutics Inc:

* ACLARIS THERAPEUTICS SUPPORTS INVESTIGATOR-INITIATED CLINICAL TRIAL OF ATI-450 FOR CYTOKINE RELEASE SYNDROME IN HOSPITALIZED PATIENTS WITH COVID-19

* ACLARIS THERAPEUTICS INC - FDA ALLOWS IND TO STUDY ATI-450 IN HOSPITALIZED PATIENTS WITH COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below